banner

HEALTH AFFAIRS

  • email
  • twitter
  • linkedin
  • facebook
Revising Our Regulatory Approach To Oral Antivirals For COVID-19
The Food and Drug Administration (FDA) continues to face scrutiny over the timeline for an emergency use authorization for both a COVID-19...